|AMGN -- USA Stock|| |
USD 190.52 1.24 0.65%
shows prevailing Real Value
of $186.939 per share. The current price of the firm is $190.52. At this time the firm appears to be fairly valued
. Macroaxis approximates value of Amgen
from analyzing the firm fundamentals
such as Profit Margin
of 9.67% and Return On Equity of 9.59% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Amgen is rated second
in last dividend paid category among related companies. It is rated third
in price to sales category among related companies fabricating about 1.07
of Price to Sales per Last Dividend Paid.
July 20, 2018
Amgen is not too risky
asset. Calculation of real value of Amgen is based on 1 month time horizon. Increasing Amgen time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.